PortfoliosLab logoPortfoliosLab logo
Cardlytics, Inc. (CDLX)
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

Company Info

ISIN
US14161W1053
CUSIP
14161W105
IPO Date
Feb 9, 2018

Highlights

Market Cap
$55.77M
Enterprise Value
$223.97M
EPS (TTM)
-$1.95
Total Revenue (TTM)
$233.27M
Gross Profit (TTM)
$103.88M
EBITDA (TTM)
-$74.51M
Year Range
$0.66 - $3.28
Target Price
$6.08
ROA (TTM)
-36.23%
ROE (TTM)
1,590.17%

Share Price Chart


Loading graphics...

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Cardlytics, Inc.

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in Cardlytics, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


Loading graphics...

S&P 500 Index

Returns By Period

Cardlytics, Inc. (CDLX) has returned -8.70% so far this year and -42.31% over the past 12 months.


Cardlytics, Inc.

1D
16.74%
1M
21.51%
YTD
-8.70%
6M
-56.79%
1Y
-42.31%
3Y*
-32.37%
5Y*
-61.19%
10Y*

Benchmark (S&P 500 Index)

1D
2.91%
1M
-5.09%
YTD
-4.63%
6M
-2.39%
1Y
16.33%
3Y*
16.69%
5Y*
10.18%
10Y*
12.16%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Monthly Returns

Based on dividend-adjusted daily data since Feb 9, 2018, CDLX's average daily return is +0.13%, while the average monthly return is +2.04%. At this rate, your investment would double in approximately 2.9 years.

Historically, 43% of months were positive and 57% were negative. The best month was Sep 2025 with a return of +138.2%, while the worst month was Mar 2020 at -56.0%. The longest winning streak lasted 4 consecutive months, and the longest losing streak was 8 months.

On a daily basis, CDLX closed higher 48% of trading days. The best single day was Sep 18, 2025 with a return of +92.7%, while the worst single day was Aug 8, 2024 at -57.1%.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2026-15.78%-10.78%21.51%-8.70%
2025-17.52%-14.05%-30.80%-20.88%25.69%-9.12%24.01%-50.00%138.24%-20.16%-36.08%-7.26%-69.00%
2024-17.05%8.51%74.79%-15.46%-28.49%-6.28%0.97%-52.83%-18.16%34.69%-5.57%-8.85%-59.72%
202329.76%-27.33%-37.71%91.16%-20.34%22.24%84.65%42.76%-0.96%-24.91%-35.75%15.70%59.34%
20221.53%-13.56%-5.21%-37.92%-24.08%-13.89%-38.14%-4.06%-29.00%0.32%-52.39%28.73%-91.25%
2021-14.36%8.31%-17.16%25.37%-22.53%19.13%-0.76%-27.93%-7.53%-6.29%-14.09%-2.20%-53.71%

Benchmark Metrics

Cardlytics, Inc. has an annualized alpha of 7.82%, beta of 1.98, and R² of 0.11 versus S&P 500 Index. Calculated based on daily prices since February 12, 2018.

  • This stock participated in 158.15% of S&P 500 Index downside but only 11.06% of its upside — more exposed to losses than it benefited from rallies.
  • R² of 0.11 means this stock moves largely independently of S&P 500 Index — capture ratios reflect limited market correlation rather than active downside protection. Consider using a more representative benchmark.

Alpha
7.82%
Beta
1.98
0.11
Upside Capture
11.06%
Downside Capture
158.15%

Return for Risk

Risk / Return Rank

CDLX ranks 32 for risk / return — below 32% of stocks on our site. The returns aren't fully compensating for the risk involved. This isn't necessarily a dealbreaker, but factor it into your decision — especially if you're risk-averse.


CDLX Risk / Return Rank: 3232
Overall Rank
CDLX Sharpe Ratio Rank: 2828
Sharpe Ratio Rank
CDLX Sortino Ratio Rank: 4444
Sortino Ratio Rank
CDLX Omega Ratio Rank: 4141
Omega Ratio Rank
CDLX Calmar Ratio Rank: 2222
Calmar Ratio Rank
CDLX Martin Ratio Rank: 2626
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

Return / Risk — by metrics

The table below present risk-adjusted performance metrics for Cardlytics, Inc. (CDLX) and compare them to a chosen benchmark (S&P 500 Index).


CDLXBenchmarkDifference

Sharpe ratio

Return per unit of total volatility

-0.27

0.90

-1.17

Sortino ratio

Return per unit of downside risk

0.61

1.39

-0.78

Omega ratio

Gain probability vs. loss probability

1.07

1.21

-0.14

Calmar ratio

Return relative to maximum drawdown

-0.55

1.40

-1.95

Martin ratio

Return relative to average drawdown

-0.87

6.61

-7.47

Explore CDLX risk-adjusted metrics in detail

Dive deeper into individual metrics with historical trends, benchmark comparisons, and performance across different time periods.

Dividends

Dividend History


Cardlytics, Inc. doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading graphics...

Worst Drawdowns

The table below displays the maximum drawdowns of the Cardlytics, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Cardlytics, Inc. was 99.57%, occurring on Mar 12, 2026. The portfolio has not yet recovered.

The current Cardlytics, Inc. drawdown is 99.33%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.57%Feb 16, 20211274Mar 12, 2026
-71.37%Feb 20, 202023Mar 23, 2020162Nov 10, 2020185
-62.39%Sep 18, 201867Dec 21, 2018130Jul 1, 2019197
-28.75%Feb 26, 201844Apr 27, 20187May 8, 201851
-28.43%Jun 19, 201829Jul 30, 201831Sep 12, 201860

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading graphics...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Cardlytics, Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Valuation

The Valuation section provides an overview of how Cardlytics, Inc. is priced in the market compared to other companies in the Internet Content & Information industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for CDLX relative to other companies in the Internet Content & Information industry. Currently, CDLX has a P/S ratio of 0.2. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items